Our previous study showed that UBQLN4 protein levels were significantly higher in tissue biopsies obtained from non-responder than in responder ESCC patients to cisplatin-based neoadjuvant chemotherapy (NAC) [8]. Here, UBQLN4 is linked to esophageal squamous cell carcinoma.